Apnimed, Inc. (APMD)Healthcare | Biotechnology | Cambridge, United States | NasdaqGS
29.71 USD
+0.99
(3.447%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 30.30 +0.59 (1.986%) ⇧ (Aug. 28, 2026, 7:46 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 6:01 a.m. EDT
The immediate outlook is driven by a sharp, high-conviction bounce off the lows. After hitting a bottom around $16, the stock has staged a robust recovery, climbing nearly 75% over the last two months to trade near its 52-week high. The recent price action shows strong momentum, with the asset surging past $32 before a brief pullback to test support, suggesting buyers are aggressively defending this new range. However, this aggressive short-term rally is entirely disconnected from the company's long-term reality. The business is fundamentally broken, posting significant losses with negative book value and no earnings to support a valuation. There is no dividend to provide income, and the lack of any recent news or analyst coverage leaves the future direction opaque. While the technical setup offers a compelling entry for a tactical swing trade, the underlying fundamentals remain too precarious to justify a long-term hold. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 22.204 |
| Market Cap | 1,183,146,752 |
| Trailing P/E | 8.32 |
| Forward P/E | -7.65 |
| Profit Margins | -26.49% |
| Website | https://apnimed.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.18840003 |
| Address1 | 39 John F. Kennedy Street |
| Address2 | 4th Floor |
| All Time High | 35.29 |
| All Time Low | 16.12 |
| Ask | 30.31 |
| Ask Size | 1 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 369,560 |
| Average Daily Volume3 Month | 538,738 |
| Average Volume | 538,738 |
| Average Volume10Days | 369,560 |
| Bid | 31.14 |
| Bid Size | 1 |
| Book Value | -53.946 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 29.71 |
| Current Ratio | 1.907 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 32.37 |
| Day Low | 28.83 |
| Display Name | Apnimed |
| Ebitda | 41,364,000 |
| Ebitda Margins | 0.34427 |
| Enterprise To Ebitda | 9.813 |
| Enterprise To Revenue | 3.378 |
| Enterprise Value | 405,888,096 |
| Eps Current Year | -0.27 |
| Eps Forward | -3.88333 |
| Eps Trailing Twelve Months | 3.57 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 28.146667 |
| Fifty Day Average Change | 1.5633316 |
| Fifty Day Average Change Percent | 0.055542335 |
| Fifty Two Week Change Percent | 18.840004 |
| Fifty Two Week High | 35.29 |
| Fifty Two Week High Change | -5.580002 |
| Fifty Two Week High Change Percent | -0.1581185 |
| Fifty Two Week Low | 16.12 |
| Fifty Two Week Low Change | 13.589998 |
| Fifty Two Week Low Change Percent | 0.84305197 |
| Fifty Two Week Range | 16.12 - 35.29 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,785,504,600,000 |
| Float Shares | 3,705,428 |
| Forward Eps | -3.88333 |
| Forward P E | -7.65065 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 65 |
| Fullday Change | 0.99 |
| Fullday Change Percent | 3.44707 |
| Fullday Price | 30.3 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.93727 |
| Gross Profits | 112,613,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.37225 |
| Held Percent Institutions | 0.18861 |
| Implied Shares Outstanding | 39,823,183 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-07-31 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. |
| Long Name | Apnimed, Inc. |
| Market | us_market |
| Market Cap | 1,183,146,752 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_573282303 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 39,002,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,146,907,670 |
| Number Of Analyst Opinions | 2 |
| Open | 29.01 |
| Operating Cashflow | -69,192,000 |
| Operating Margins | 0.80227 |
| Payout Ratio | 0.0 |
| Phone | 617 500 8880 |
| Post Market Change | 0.59000015 |
| Post Market Change Percent | 1.9858639 |
| Post Market Price | 30.3 |
| Post Market Time | 1,787,960,813 |
| Previous Close | 28.72 |
| Price Eps Current Year | -110.03703 |
| Price Hint | 2 |
| Price To Book | -0.5507359 |
| Price To Sales Trailing12 Months | 9.847247 |
| Profit Margins | -0.26489002 |
| Quick Ratio | 1.165 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.99 |
| Regular Market Change Percent | 3.44707 |
| Regular Market Day High | 32.37 |
| Regular Market Day Low | 28.83 |
| Regular Market Day Range | 28.83 - 32.37 |
| Regular Market Open | 29.01 |
| Regular Market Previous Close | 28.72 |
| Regular Market Price | 29.71 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 531,899 |
| Revenue Growth | 26.088 |
| Revenue Per Share | 22.204 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 39,823,183 |
| Shares Percent Shares Out | 0.010199999 |
| Shares Short | 0 |
| Short Name | Apnimed, Inc. |
| Short Ratio | 0.0 |
| Source Interval | 15 |
| State | MA |
| Symbol | APMD |
| Target High Price | 60.0 |
| Target Low Price | 41.0 |
| Target Mean Price | 50.5 |
| Target Median Price | 50.5 |
| Total Cash | 46,886,000 |
| Total Cash Per Share | 8.317 |
| Total Debt | 39,347,000 |
| Total Revenue | 120,150,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.57 |
| Trailing P E | 8.322128 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 28.146667 |
| Two Hundred Day Average Change | 1.5633316 |
| Two Hundred Day Average Change Percent | 0.055542335 |
| Type Disp | Equity |
| Volume | 531,899 |
| Website | https://apnimed.com |
| Zip | 2,138 |